Tag Archives: 2011 BIO International Convention

Five international biotech countries to watch

DSC00128

Scientific American released their third annual WorldView: A Global Biotechnology Perspective at the 2011 BIO International Convention which includes a Bio Innovation Scorecard. The Scorecard reviews individual country biotechnology programs and policies aimed at growing local innovative biotechnology sectors. Based on the results of the Bio Innovation Scorecard, here’s our list of 5 biotechs to watch: 5.  Malaysia: Ranking third in the world for the best Enterprise Support of its biotech industry by Scientific American’s Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Managing Biotech Technological Innovation in a New Era

Written by Kelly Cappio, BIO. This session focused on technological innovations and how they can be used to prevent, identify, or respond to new natural or man-made threats. As stated by Dr. Alan Rudolph, “We face a very dynamic threat space.” Dr. Rudolph, Director of the Chemical and Biological Technologies Directorate at the Defense Threat Reduction Agency, discussed the strategic thrust of the agency and its recent focus on new diagnostic technologies, such as MIMIC, Read More >

Health  |  Leave a comment  |  Email This Post
Tags: ,

Biotechnology – Creating a positive political and social environment

Tony Blair at 2011 BIO International Convention

“I think it’s important that government stands up for proper science,” Former British Prime Minister Tony Blair said during the Tuesday keynote luncheon at the 2001 BIO International Convention. “You know I had a lot of battles over this when I was prime minister – with various groups.” This was a familiar story to many of the attendees who regularly face a number of social and political hurdles in bringing their innovative products to market: Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , ,

USTR: TPP to have High IP Standards to “Stand Alongside other Treaty Agreements in the Area”

Stan McCoy, Assisant U.S. Trade Representative for Intellectual Property and Innovation, spoke at BIO’s 2011 Convention session titled The Trans-Pacific Partnership and the Importance of Intellectual Property Rights: Attracting Investment in Biotechnology.  The session covered the ongoing treaty negotiations and the relevance of different IP provisions to the biotechnology industry.  Issues of particular importance to the biotechnology industry yet to be revelead to the public include language tabled for data protection and patent linkage.  While USTR specific language is not available, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Podcast: 2011 Dr. Paul Janssen Award winner Dr. Napoleone Ferrara

JOHNSON & JOHNSON DR. PAUL JANSSEN FOR BIOMEDICAL RESEARCH AWARD WINNER

Dr. Napoleone Ferrara, a Genentech Fellow, was named the 2011 winner of The Dr. Paul Janssen Award for Biomedical Research. Dr. Ferrrara was recognized for his research on angiogenesis, the process of new blood vessel formation, and the isolation and cloning of vascular endothelial growth factor (VEGF), a major regulator of angiogenesis in physiology and disease. Download the podcast

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,